MS drug Gilenya tied to brain infection
FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare
Read MoreFaulty Pharmaceutical Drugs Resources
FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare
Read MoreThe Food and Drug Administration (FDA) is advising consumers not to purchase or use Ortiga, an unapproved product promoted for
Read MoreFDA has required the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated to better describe the
Read MoreIn 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration to change the labels of the
Read More